The Board of Directors of Siegfried Holding AG has appointed Marcel Imwinkelried as the new CEO with effect as of September 1, 2024. He will succeed Reto Suter, who has been leading the Siegfried Group as CEO ad interim since May 1, 2024, and will now focus again on his role as CFO. Read the media release: https://lnkd.in/dxUwtzcT
Siegfried
Fabrication de produits pharmaceutiques
Zofingen, Aargau 27 096 abonnés
Expect more
À propos
Expect more with Siegfried as your preferred partner. Siegfried is a preferred manufacturing and service partner in the global pharmaceutical industry. Our company is looking back on more than 150 years of unmatched quality and combines both chemistry and pharmaceutics under one roof. We develop and manufacture active pharmaceutical ingredients for pharmaceutical clients with R&D programs, related intermediates and controlled substances. Siegfried also offers development and production of finished dosage forms, including sterile fillings. Approximately 3600 dedicated employees in Switzerland, Germany, France, Spain, Malta, China and the USA establish innovative and integrated solutions for our customers that bring a significant added value.
- Site web
-
http://www.siegfried.ch
Lien externe pour Siegfried
- Secteur
- Fabrication de produits pharmaceutiques
- Taille de l’entreprise
- 1 001-5 000 employés
- Siège social
- Zofingen, Aargau
- Type
- Société cotée en bourse
- Fondée en
- 1873
- Domaines
- Formulation Development, Analytical Development, Solid Dosage Forms, Parenterals (vials, ampoules, cartridges, syringes), Ophtalmics (liquids and semisolids), API, Active Pharmaceutical Ingredient, Exclusive Synthesis, High Potency, Intermediates, Sterile Filling, biologics finished dosage forms et spray drying
Lieux
Employés chez Siegfried
Nouvelles
-
Siegfried a republié ceci
The Siegfried Acceleration Hub is here! As our hub for early-phase CDMO services, it will provide comprehensive support to customers in the pre-clinical and clinical development and manufacturing of Drug Substances. #growth #earlydevelopment #strongestteam
-
The Siegfried Acceleration Hub is here! As our hub for early-phase CDMO services, it will provide comprehensive support to customers in the pre-clinical and clinical development and manufacturing of Drug Substances. #growth #earlydevelopment #strongestteam
-
Siegfried has completed the acquisition of an early-phase CDMO site in Grafton, Wisconsin (US) from Curia Global, strengthening Siegfried’s customer offering for Drug Substances in terms of capabilities and geography. Read the media release: https://lnkd.in/dN6KKgEy #mediarelease #growth #earlydevelopment
Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsin (US) - Siegfried
https://www.siegfried.ch
-
The Intercompany Games held in Barcelona closed with record participation. More than 270 employees from our Siegfried Barberà and Siegfried El Masnou sites participated in these solidarity games that raised more than 24,000 Euros to support projects promoted by the Fundación Josep Carreras contra la Leucemia and the Associació 8000 estels, both focused on the fight against cancer in its different types, and the Asociación Norte Joven in its mission to promote social and labor integration of socially disadvantaged adolescents. The team spirit, healthy competition and, above all, the commitment of all Siegfried employees in such a noble cause made this event a real success once again. Congratulations to unit events for organizing these Intercompany Games and to the associations for the great work they are doing. #teamwork #givingback #strongestteam
-
-
Last week we welcomed the University of Applied Sciences Northwestern Switzerland (FHNW) and the Foundation Board at our headquarters to discuss the importance of cooperation between academic and industrial organizations as well as access to specialists and new technologies. Our Siegfried R&D team has had many fruitful collaborations with FHNW in the past, including many Bachelor theses, publications and participation in a patent application.
Wir danken unserer Gastgeberin der Siegfried in Zofingen für die Gelegenheit, die Stiftung FHNW und die Hochschule für Life Sciences FHNW unseren Gästen vorzustellen. Einige Quotes aus den Beiträgen: - "Die Zusammenarbeit zwischen Akademie und Industrie ist sehr wichtig." Dr. Thomas Carl, Head Process R&D & Scale-Up Siegfried AG - "Nicht nur Roche, sondern auch die Zulieferer sind auf qualifizierte Fachkräfte angewiesen." juerg erismann, Präsident der Stiftung FHNW - "Wir brauchen Innovationen, um neue Lösungen und Technologien zu entwickeln." Andreas Koch, Vize-Präsident der Stiftung FHNW - "Unsere Studierenden profitieren am Campus Muttenz von einer ausgezeichneten Infrastruktur." Prof. Dr. Falko Schlottig, Direktor der Hochschule für Life Sciences FHNW - "Wir danken der Stiftung FHNW für die Unterstützung bei der Erforschung der mRNA-Technologie." Prof. Dr. Oya Tagit, Team Leader BioInterfaces am Institute for Chemistry and Bioanalytics - "Der Studiengang Chemie an der Hochschule für Life Sciences FHNW hat mich überzeugt: Die Labore sind auf einem tollen Stand." Livia Müller, Studentin Mehr dazu in der Präsentation.
-
EGS Beteiligungen AG exercised its right to convert one of the convertible bonds issued in December 2020 with a coupon of 0.650% and a nominal value of CHF 40m into shares. Read the press release to learn more: https://lnkd.in/dJYHwrU9 #announcement #pressrelease #CDMO #bonds
EGS Beteiligungen AG exercises right to convert bond and increases its shareholding in Siegfried to 6.2% registered shares - Siegfried
https://www.siegfried.ch
-
Siegfried to acquire a CDMO specialized in early-phase development and manufacturing services in Grafton, Wisconsin (US). The new site is set to strengthen Siegfried's customer offering for Drug Substances in terms of capabilities and geography. Read more in the press release: https://lnkd.in/dzXDAVTq #announcement #pressrelease #growth #earlyphasedevelopment #CDMO
Siegfried to acquire an early-phase CDMO in Wisconsin (US) to strengthen its Drug Substances service offering - Siegfried
https://www.siegfried.ch
-
What is your company doing to meet the ever-increasing expectations of investors, shareholders and customers in relation to sustainability targets while complying with important political initiatives such as the European Green Deal? This was a key topic at the recent #DCAT Sustainability Summit roundtable where Luca Dalla Torre, Siegfried General Counsel and Chairman of the Sustainability Board, took part. Alongside industry experts, Annette Quincy-Garg, Nelleke Barning, and moderator Kelsey Achenbach, they discussed insights into metrics, common reporting standards and key requirements for assessing a company's environmental and sustainability performance. #bio #pharma #biopharma #pharmaceutical #sustainability #networking #event #dcat
-
-
Meet Patrick, who joined our Siegfried Hameln site after completing his studies. Throughout his time with Siegfried, he continues to learn and be challenged everyday. Want to learn more about Patrick's experience? Check out his full story https://lnkd.in/gYtVrFW8 #EmployeeAmbassador #Teamwork #ContinuousLearning #CareerGrowth #FinanceAndControlling
-